Cointime

Glycominds

company

About

Glycominds develops and commercializes autoimmune and chronic inflammatory disease management tools focused on multiple sclerosis.

  • 11 - 50

Highlights

Total Funding Amount
$1M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$1M
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Close

Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1M
Glycominds has raised a total of $1M in funding over 2 rounds. Their latest funding was raised on Jan 1, 2005 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2005 Series Unknown $1M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Glycominds is funded by 1 investors. Millennium II Materials Technology Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Millennium II Materials Technology Fund — Series Unknown
Cointime
เนื้อหา
บริษัท